Centene(US:CNC)2026-02-06 15:02Financial Data and Key Metrics Changes - The company reported a fourth quarter adjusted diluted loss per share of $1.19, contributing to a full year adjusted diluted EPS of $2.08 for 2025, which was slightly ahead of expectations [6][7][38] - The fourth quarter GAAP diluted loss per share was $2.24, including a $389 million net loss from divesting the remaining Magellan business [38] - The company anticipates full year 2026 adjusted EPS to exceed $3, representing over 40% year-over-year growth [8][58] Business Line Data and Key Metrics Changes - Medicaid's health benefits ratio (HBR) improved to 93.0% in Q4, showing a 40 basis points sequential improvement and 190 basis points improvement from Q2 levels [10][40] - The Marketplace segment's HPR was about a point higher than forecasted, with medical cost trends slightly better than expectations in Q4 [42] - The Medicare segment delivered strong results, with Q4 fundamentals in line with expectations, and the company aims for break-even in Medicare Advantage by 2027 [26][27][46] Market Data and Key Metrics Changes - The company closed 2025 with approximately 12.5 million Medicaid members, with expectations of a 5%-6% decline in member months for 2026 [41][51] - Marketplace membership is projected to be around 3.5 million by the end of Q1 2026, down from 5.5 million in December [22][52] - Medicare segment premium revenue is expected to grow by approximately $7.5 billion, driven by the PDP business and membership growth [53] Company Strategy and Development Direction - The company is focused on restoring Medicaid to sustainable profitability while improving quality outcomes for members [9] - Key levers for Medicaid improvement include optimizing networks, implementing clinical programs, and enhancing fraud detection [11][14] - The company is integrating data and AI into operations to enhance efficiency and member experience [32][34] Management's Comments on Operating Environment and Future Outlook - Management acknowledged that 2025 was challenging but expressed confidence in the ability to execute against the 2026 outlook, with expectations for margin expansion [36] - The company is proactively engaging with state partners to ensure appropriate rate adjustments and program reforms [99][102] - Management emphasized the importance of data-driven decisions and the need for timely adjustments to rates based on recent trends [100][102] Other Important Information - The company ended 2025 with about $400 million in cash available for corporate use and reduced debt by $189 million, resulting in a debt-to-cap ratio of 46.5% [48] - The adjusted SG&A expense ratio for Q4 was 7.5%, bringing the full year to 7.4%, reflecting continued discipline [48] Q&A Session Summary Question: Medicaid rate expectation for 4.5% - Management explained that the 4.5% rate assumption is prudent, considering the favorable maturation of 2025 rates and ongoing efforts to manage trends [63][65] Question: Trend comparison for Medicaid in 2025 - Management indicated that the 2025 trend was in the mid-6s, with the 2026 assumption reflecting a net trend of mid-4s based on recent performance [67][69] Question: Confidence in exchange member dynamics - Management expressed confidence in margin improvement for exchanges, citing improved visibility and historical data to support pricing strategies [76][78] Question: Membership attrition in Medicaid - Management discussed expectations for continued attrition in membership, considering state eligibility tightening and program changes [88][90] Question: Actuarial soundness lookback process - Management highlighted efforts to shorten the lookback period for actuarial adjustments and the importance of recent data in rate negotiations [96][98] Question: Segment margins in 2026 guidance - Management provided insights into expected margins, indicating opportunities for improvement across all business lines, with specific targets for Medicaid and Medicare segments [105][106]